Lonza

CompanyBasel, Switzerland· Pharma

Swiss contract manufacturer for pharma and biotech.

Minutes holds 1 development naming Lonza, recorded from October 2026.

Activity

Lonza

Lonza raises its medium-term ambitions

ResultsLonzaPharma14 OctThe Wall Street Journal

Elsewhere in Pharma

Past 3 months in Activity →

Aurora Cannabis again tells shareholders to reject Curaleaf's revised hostile bid

M&AAurora Cannabis, Curaleaf, +1Pharma14 OctPR Newswire

GSK to invest more than $800 million in a Pennsylvania manufacturing hub

ExpansionGSKPharma13 OctManufacturing Dive